Drugs / atevirdine mesylate
atevirdine mesylate
also known as
Atevirdine · U-87201E · Atevirdina · Atevirdine mesilate · Atevirdine methanesulfonate · ATEVIRDINE SULPHATE
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT00000742 | ? → Oct 1993 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1 | NCT00000753 | ? → Feb 1995 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00002322 | — | HIV infectious disease | Pharmacia and Upjohn | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00002094 | — | HIV infectious disease | Pharmacia and Upjohn | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | atevirdine mesylate | “To determine the time course of development of resistance to atevirdine mesylate ( U-87201E ) in patients with HIV isolates showing in vitro resistance to zidovudine ( AZT ).” NCT00002094 ↗ |
| Known as | Atevirdina | ChEMBL registry synonym — accepted as the source's own label CHEMBL280527 ↗ |
| Known as | Atevirdine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000753 ↗ |
| Known as | Atevirdine mesilate | ChEMBL registry synonym — accepted as the source's own label CHEMBL280527 ↗ |
| Known as | Atevirdine methanesulfonate | ChEMBL registry synonym — accepted as the source's own label CHEMBL280527 ↗ |
| Known as | ATEVIRDINE SULPHATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL280527 ↗ |
| Known as | U-87201E | “To determine the time course of development of resistance to atevirdine mesylate ( U-87201E ) in patients with HIV isolates showing in vitro resistance to zidovudine ( AZT ).” NCT00002094 ↗2“A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC” NCT00000753 ↗ “two different doses of atevirdine mesylate (U-87201E)” NCT00002322 ↗ |
| Modality | Small molecule | — CHEMBL280527 ↗ |
| Route | Oral | “Taking Oral U-87201E” NCT00002094 ↗ |